Finance

Lists
Why is IFRX down 5.65%?
Dive Deeper
IFRX:NASDAQ
Inflarx NV
$1.17
-5.65%
(-0.070) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IFRX...
Open
$1.23
High
$1.24
Low
$1.15
Mkt. cap
172.42M
Avg. vol.
963.13K
Volume
220.95K
52-wk high
$2.94
52-wk low
$0.80
EPS
-$0.37
Beta
2.38
Shares outstanding
147.37M
No. of employees
65
Open
$1.23
High
$1.24
Low
$1.15
Mkt. cap
172.42M
Avg. vol.
963.13K
Volume
220.95K
52-wk high
$2.94
52-wk low
$0.80
EPS
-$0.37
Beta
2.38
Shares outstanding
147.37M
No. of employees
65
News stories
From web sources and news partners
About Inflarx NV
CEONiels C. Riedemann
Employees65
Founded2007
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteinflarx.de
Analyst ratings
Based on 2 analysts giving stock ratings to IFRX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for IFRX in the last 3 months.
Highest
Current $1.17
$8.00 (+583.76%)
Average
$8.00 (+583.76%)
Lowest
$8.00 (+583.76%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Keller
H.C. Wainwright
Buy
Reiterated
$8.00
+583.8%
11/03/2026
Joseph Stringer
Needham
Buy
Initiated
$8.00
+583.8%
09/14/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$6.00
+412.8%
08/06/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
$5.00
+327.4%
08/06/2026
Mazahir Alimohamed
Oppenheimer
Buy
Reiterated
$9.00
+669.2%
07/20/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
$9.00
+669.2%
06/30/2026
Ryan Deschner
Raymond James
Buy
Maintained
$9.00
+669.2%
05/13/2026
Yatin Suneja
Guggenheim
Buy
Maintained
$14.00
+1,096.6%
05/08/2026
Andreas Argyrides
Chardan Capital
Buy
Maintained
$5.00
+327.4%
04/24/2026
Last report
Nov 3, 2026
Fiscal period
Q3 2026
-€0.02 / -€0.05
+65.71%beat
Revenue / Est. (EUR)
- / 0.00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-33.93K
-
-
-
Cost of goods sold
4.86M
-
-
-
Cost of revenue
4.86M
-
-
-
Research and development expenses
5.26M
4.17M
4.74M
3.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.36M
3.29M
2.58M
2.77M
Operating expense
7.97M
7.21M
7.05M
5.54M
Total operating expenses
12.83M
7.21M
7.05M
5.54M
Operating income
-12.86M
-7.21M
-7.05M
-5.54M
Other non operating income
1.90M
803.16K
-7.91M
3.77M
EBT including unusual items
-10.64M
-5.59M
-10.65M
-2.44M
EBT excluding unusual items
-10.64M
-5.59M
-10.65M
-2.44M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-649.05K
-247.91K
-266.57K
-265.72K
Net income
-10.64M
-5.59M
-10.65M
-2.44M
Net profit margin
31,364.81%
-
-
-
Earnings per share
-0.15
-0.08
-0.09
-0.02
Interest and investment income
391.31K
334.77K
770.66K
-
Interest expense
-17.44K
-14.81K
-14.64K
-14.12K
Net interest expenses
373.87K
319.96K
756.02K
-14.12K
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.77M
-7.12M
-6.96M
-5.46M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps